Biogenera 2026 crowdfunding raise on CrowdFundMe (no longer listed)

Last seen on CrowdFundMe’s listing

La piattaforma biotecnologica brevettata che sviluppa farmaci a DNA per curare le malattie più gravi, tra cui i tumori pediatrici

  • Listed on CrowdFundMe
  • Equity
  • HealthCare & LifeScience · Italy

Funding history

357 readings

Biogenera 2026: amount raised over time The amount raised rose from €639,821 on 11 October 2026 to €728,813 on 26 October 2026, over 357 readings. Target €249,984. Maximum €4,999,968.

The maximum, €4,999,968, is above the top of the chart.

Biogenera 2026: amount raised per day, 14 days to 26 Oct 13 Oct €4,608; 14 Oct €0; 15 Oct €3,168; 16 Oct €3,168; 17 Oct €0; 18 Oct €0; 19 Oct €6,912; 20 Oct €1,440; 21 Oct €11,808; 22 Oct €22,752; 23 Oct €2,880; 24 Oct €0; 25 Oct €0; 24 hours to 26 Oct €31,104. Usual pace €2,880 a day, the median of the previous 7 days. 13 Oct: €4,60814 Oct: €015 Oct: €3,16816 Oct: €3,16817 Oct: €018 Oct: €019 Oct: €6,91220 Oct: €1,44021 Oct: €11,80822 Oct: €22,75223 Oct: €2,88024 Oct: €025 Oct: €024 hours to 26 Oct: €31,104
Raised €88,992 while Raise Sonar tracked it, from 11 Oct to 26 Oct.

About Biogenera 2026

Summarised by Raise Sonar from Biogenera 2026’s CrowdFundMe pitch

Biogenera S.p.A. is a Bologna-based PMI Innovativa founded in 2009 that develops next-generation DNA-based drugs using its patented MyGenera™ platform. Its lead asset BGA002 is described as the first drug designed to block the MYCN oncogene, with GMP-certified production complete and a Phase I trial planned at Padova in Q1 2027. Revenue is intended to come from out-licensing to international pharmaceutical companies through upfront, milestone and royalty payments. This raise funds the clinical trial and related regulatory and production work, with a stated minimum of €250.000 and scenarios of €2,5 milioni and €5 milioni.

Read the full pitch on CrowdFundMe (opens in a new tab)

Similar raises open now

Live raises

Hear when the next Healthtech raise opens

Set a rule and we email you the moment a raise that matches it goes live.

Free to start. Alerts come with the Alerts plan.

Set up alerts

The raise in figures

Raised

€728,813

of €4,999,968 maximum

14%

of maximum

€0Target €249,984 met€4,999,968

Investors
199
Minimum investment
€576
Pre-money valuation
€90M

At target: €90.2M post-money · 0.28% equity offered

Last updated

↳ CrowdFundMe · last checked 8 d ago

About this raise

Biogenera 2026’s equity crowdfunding raise is no longer listed on CrowdFundMe. The company is based in Italy, and CrowdFundMe lists it under HealthCare & LifeScience. The round is for shares, made under the EU’s European Crowdfunding Service Providers Regulation (ECSPR).

The round values Biogenera 2026 at €89.9M pre-money. The target is €249,984, with a maximum of €4.99M. When last reported, it had raised €728,813 from 199 investors, 14% of its maximum. Tickets started at €576.

ECSPR sets one set of rules for licensed crowdfunding platforms across the EU, including what a raise has to disclose to investors. Buying shares makes investors part-owners of Biogenera 2026. These figures are CrowdFundMe’s own, as Raise Sonar last read them on .

No longer listed

No longer listed

More like this

About Raise Sonar

Every live equity crowdfunding raise, in one place

We track raises across Crowdcube, Republic, Wefunder, StartEngine and more, and tell you when they open and before they close.

  • Launch alerts

    An email when a raise matching your filters opens.

  • Close reminders

    Follow a raise and hear from us 72 and 24 hours before it closes.

  • One search, every platform

    Filter live raises by sector, country, minimum and platform.

  • The weekly newsletter

    New raises and raises closing soon, every Monday.